Literature DB >> 20378545

C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation.

Sébastien Roger1, Ludovic Gillet, Alberto Baroja-Mazo, Annmarie Surprenant, Pablo Pelegrin.   

Abstract

P2X(7) receptors (P2X(7)R) are ATP-gated calcium-permeable cationic channels structurally unique among the P2X family by their much longer intracellular C-terminal tail. P2X(7)Rs show several unusual biophysical properties, in particular marked facilitation of currents and leftward shift in agonist affinity in response to repeated or prolonged agonist applications. We previously found the facilitation at rat P2X(7)R resulted from a Ca(2+)-calmodulin-dependent process and a distinct calcium-independent process. However, P2X(7)Rs show striking species differences; thus, this study compared the properties of ATP-evoked facilitation of currents in HEK293 cells transiently expressing the human or rat P2X(7)R as well as rat/human, human/rat chimeric, and mutated P2X(7)Rs. Facilitation at the human P2X(7)R was 5-fold slower than at the rat P2X(7)R. Facilitation did not resulting from an increase of receptor addressing the plasma membrane. We found the human P2X(7)R shows only calcium-independent facilitation with no evidence for calmodulin-dependent processes, nor does it contain the novel 1-5-16 calmodulin binding domain present in the C terminus of rat P2X(7)R. Replacement of three critical residues of this binding domain from the rat into the human P2X(7)R (T541I, C552S, and G559V) reconstituted the Ca(2+)-calmodulin-dependent facilitation, leaving the calcium-independent facilitation unaltered. The leftward shift in the ATP concentration-response curve with repeated agonist applications appears to be a property of the calcium-independent facilitation process because it was not altered in any of the chimeric or mutated P2X(7)Rs. The absence of Ca(2+)-dependent facilitation at the human P2X(7)R may represent a protective adaptation of the innate immune response in which P2X(7)R plays significant roles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378545      PMCID: PMC2878516          DOI: 10.1074/jbc.M109.053082

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Identification of Thr283 as a key determinant of P2X7 receptor function.

Authors:  M T Young; P Pelegrin; A Surprenant
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

Review 2.  Physiology and pathophysiology of purinergic neurotransmission.

Authors:  Geoffrey Burnstock
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

3.  Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders.

Authors:  Angelika Erhardt; Susanne Lucae; Paul G Unschuld; Marcus Ising; Nikola Kern; Daria Salyakina; Roselind Lieb; Manfred Uhr; Elisabeth B Binder; Martin E Keck; Bertram Müller-Myhsok; Florian Holsboer
Journal:  J Affect Disord       Date:  2007-01-02       Impact factor: 4.839

4.  Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor.

Authors:  Pablo Pelegrin; Annmarie Surprenant
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

5.  Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP.

Authors:  Mark T Young; Pablo Pelegrin; Annmarie Surprenant
Journal:  Mol Pharmacol       Date:  2006-10-10       Impact factor: 4.436

6.  A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.

Authors:  Suran L Fernando; Bernadette M Saunders; Ronald Sluyter; Kristen K Skarratt; Hazel Goldberg; Guy B Marks; James S Wiley; Warwick J Britton
Journal:  Am J Respir Crit Care Med       Date:  2006-11-09       Impact factor: 21.405

7.  Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding.

Authors:  Sébastien Roger; Pablo Pelegrin; Annmarie Surprenant
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

Review 8.  The P2X7 receptor as a therapeutic target.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez-Cara; Delia Preti; Pier Andrea Borea; Stefania Gessi
Journal:  Expert Opin Ther Targets       Date:  2008-05       Impact factor: 6.902

Review 9.  Liaisons dangereuses: P2X(7) and the inflammasome.

Authors:  Francesco Di Virgilio
Journal:  Trends Pharmacol Sci       Date:  2007-08-10       Impact factor: 14.819

10.  Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.

Authors:  L Stokes; L-H Jiang; L Alcaraz; J Bent; K Bowers; M Fagura; M Furber; M Mortimore; M Lawson; J Theaker; C Laurent; M Braddock; A Surprenant
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

View more
  27 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  Regulation of ATP-gated P2X channels: from redox signaling to interactions with other proteins.

Authors:  Stanko S Stojilkovic; Elías Leiva-Salcedo; Milos B Rokic; Claudio Coddou
Journal:  Antioxid Redox Signal       Date:  2013-09-25       Impact factor: 8.401

3.  C terminus of the P2X7 receptor: treasure hunting.

Authors:  Helio Miranda Costa-Junior; Flávia Sarmento Vieira; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2011-01-27       Impact factor: 3.765

Review 4.  Neuronal P2X7 Receptors Revisited: Do They Really Exist?

Authors:  Peter Illes; Tahir Muhammad Khan; Patrizia Rubini
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

5.  Many ways to dilate the P2X7 receptor pore.

Authors:  Pablo Pelegrín
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Interaction of alpha1D-adrenergic and P2X(7) receptors in the rat lacrimal gland and the effect on intracellular [Ca2+] and protein secretion.

Authors:  Darlene A Dartt; Robin R Hodges
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

7.  A residue in the TRPM2 channel outer pore is crucial in determining species-dependent sensitivity to extracellular acidic pH.

Authors:  Jie Zou; Wei Yang; David J Beech; Lin-Hua Jiang
Journal:  Pflugers Arch       Date:  2011-04-20       Impact factor: 3.657

8.  Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization.

Authors:  Alanna E McCarthy; Craig Yoshioka; Steven E Mansoor
Journal:  Cell       Date:  2019-10-03       Impact factor: 41.582

9.  Pharmacological properties of the rhesus macaque monkey P2X7 receptor.

Authors:  Helen J Bradley; Liam E Browne; Wei Yang; Lin-Hua Jiang
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 10.  P2X7 receptor: a critical regulator and potential target for breast cancer.

Authors:  Xiaodi Zhu; Qianqian Li; Wei Song; Xiaoxiang Peng; Ronglan Zhao
Journal:  J Mol Med (Berl)       Date:  2021-01-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.